Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
No published human trial has used a standardized adverse-event grading scale for MOTS-c
1-2 vials per day, only via deep intramuscular injection
Unlike many weight loss compounds that work through appetite suppression or metabolic stimulation, AOD-9604 directly targets fat tissue at the receptor level, making it one of the most precise fat reduction tools available in peptide therapy
Retatrutide produced the largest weight loss of the class up to ~24.2% at 48 weeks in Phase 2 so the absolute amount of lean mass lost can be larger simply because total loss is larger
The most-shared online before-and-after photos are taken in this window
US$ 20.43
US$ 23.89
01053-X/asset/68ad1d8b-bb7e-4ca0-8f89-99384d885ca3/main.assets/gr2.jpg)
US$ 25.09
